Advertisement
Advertisement
SDGR
Schrodinger, Inc. Common Stock
29.82
USDSponsored
+1.05
+3.65%
Nov 06, 15:59 UTC -5
Closed
After-Market
30.09
+0.27
+0.92%
Schrodinger, Inc. Common Stock (SDGR) Earnings
SDGR Earnings Reports
Positive Surprise Ratio
SDGR beat 16 of 28 last estimates.
57%
Next Report
Date of Next Report
Feb 23, 2027
Estimate for Q4 26 (Revenue/ EPS)
$76.18M
/-$0.20
Implied change from Q3 26 (Revenue/ EPS)
+18.12%
/-60.00%
Implied change from Q4 25 (Revenue/ EPS)
-12.68%
/-144.44%
Schrodinger, Inc. Common Stock earnings per share and revenue
On Nov 04, 2026, SDGR reported earnings of -0.50 USD per share (EPS) for Q3 26, beating the estimate of -0.70 USD, resulting in a 29.57% surprise. Revenue reached 64.49 million, compared to an expected 48.20 million, with a 33.79% difference. The market reacted with a +0.88% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 6 analysts forecast an EPS of -0.20 USD, with revenue projected to reach 76.18 million USD, implying an decrease of -60.00% EPS, and increase of 18.12% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
10x Genomics, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.15
Surprise
+43.35%
Doximity, Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$0.35
Actual
$0.36
Surprise
+0.56%
iRhythm Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.06
Actual
$0.82
Surprise
+1,214.10%
Privia Health Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.09
Actual
$0.10
Surprise
+3.73%
Enovis Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.78
Actual
$0.88
Surprise
+12.07%
Evolent Health, Inc Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.05
Actual
$0.06
Surprise
+13.21%
Fulgent Genetics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.66
Actual
-$0.09
Surprise
+86.43%
Health Catalyst, Inc Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.03
Surprise
+38.14%
CareCloud, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.11
Actual
$0.14
Surprise
+19.35%
Nyxoah SA Ordinary Shares
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.30
Actual
-$0.17
Surprise
+42.29%
FAQ
What were Schrodinger, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Schrodinger, Inc. Common Stock reported EPS of -$0.50, beating estimates by 29.57%, and revenue of $64.49M, 33.79% above expectations.
How did the market react to Schrodinger, Inc. Common Stock's Q3 2026 earnings?
The stock price moved up 0.88%, changed from $28.52 before the earnings release to $28.77 the day after.
When is Schrodinger, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 23, 2027.
What are the forecasts for Schrodinger, Inc. Common Stock's next earnings report?
Based on 6
analysts, Schrodinger, Inc. Common Stock is expected to report EPS of -$0.20 and revenue of $76.18M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.